Canada Pension Plan Investment Board’s Meridian Bioscience Inc VIVO Stock Holding History

Canada Pension Plan Investment Board’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-48,200	Closed	-$1.6M	–	1245
2022 Q4	$1.6M	Sell	48,200 -54,600	-53%	-$1.76M	﹤0.01%	765
2022 Q3	$3.24M	Buy	+102,800	New	+$3.33M	0.01%	597
2019 Q3	–	Sell	-50,000	Closed	-$594K	–	1318
2019 Q2	$594K	Buy	+50,000	New	+$602K	﹤0.01%	1080

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Canada Pension Plan Investment Board's VIVO Position: Q1 2023 in Review

Canada Pension Plan Investment Board sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 48,200 shares — an estimated $1.6M sold.

Canada Pension Plan Investment Board first reported a position in VIVO in Q2 2019 and held it in 3 quarters. The position peaked at $3.24M in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Canada Pension Plan Investment Board reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Canada Pension Plan Investment Board sold 48,200 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.6M.
Canada Pension Plan Investment Board first reported a position in Meridian Bioscience Inc in Q2 2019 and held it in 3 quarters.
Canada Pension Plan Investment Board's Meridian Bioscience Inc position peaked at $3.24M in Q3 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2023, filed 15 May 2023.